Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 23, 2016 08:30 ET | Source: Pernix Therapeutics Holdings, Inc.

Pernix Therapeutics Announces the Issuance of New Orange Book Patent for Zohydro® ER With BeadTek™ CII

MORRISTOWN, N.J., Feb. 23, 2016 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, today announced that the United States Patent and Trademark...
February 18, 2016 16:01 ET | Source: Pernix Therapeutics Holdings, Inc.

Pernix Therapeutics to Present at RBC Capital Markets 2016 Global Healthcare Conference

MORRISTOWN, N.J., Feb. 18, 2016 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, announced today that Doug Drysdale, Chairman and Chief...
December 01, 2015 16:30 ET | Source: Pernix Therapeutics Holdings, Inc.

Pernix Therapeutics to Present at Oppenheimer 26th Annual Healthcare Conference

MORRISTOWN, N.J., Dec. 01, 2015 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, announced today that Doug Drysdale, Chairman and Chief...
November 13, 2015 07:00 ET | Source: Pernix Therapeutics Holdings, Inc.

Pernix Therapeutics to Present at Stifel 2015 Healthcare Conference

MORRISTOWN, N.J., Nov. 13, 2015 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, announced today that Doug Drysdale, Chairman, President...
November 12, 2015 11:15 ET | Source: Pernix Therapeutics Holdings, Inc.

Pernix Therapeutics Holdings, Inc. Announces Positive Interim Results From a Phase IV Study to Assess and Compare the Effects of Silenor 6 mg and zolpidem 10 mg on Balance, Cognitive Performance, and Arousability

MORRISTOWN, N.J., Nov. 12, 2015 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, today announced positive interim results from a Phase IV...
November 10, 2015 16:30 ET | Source: Pernix Therapeutics Holdings, Inc.

Pernix Therapeutics to Host Meetings at Upcoming Conferences

MORRISTOWN, N.J., Nov. 10, 2015 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, announced today that Doug Drysdale, Chairman, President and...
November 05, 2015 06:50 ET | Source: Pernix Therapeutics Holdings, Inc.

Pernix Therapeutics Reports Third Quarter 2015 Financial Results

Revenue Increases 54% Year-Over-Year Company Reiterates Financial Guidance MORRISTOWN, N.J., Nov. 05, 2015 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) (“Pernix” or “the...
October 22, 2015 09:00 ET | Source: Pernix Therapeutics Holdings, Inc.

Pernix Therapeutics Holdings, Inc. to Report Third Quarter 2015 Financial Results on Thursday, November 5, 2015

MORRISTOWN, N.J., Oct. 22, 2015 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, announced today that it will release its 2015 third quarter...
September 24, 2015 09:23 ET | Source: Pernix Therapeutics Holdings, Inc.

Pernix Announces the Issuance of Zohydro ER With BeadTek Formulation Patent

MORRISTOWN, N.J., Sept. 24, 2015 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, today announced that the central patent for Zohydro ER®...
September 09, 2015 07:30 ET | Source: Pernix Therapeutics Holdings, Inc.

Pernix Presents Data on Novel Extended Release Formulation of Hydrocodone Bitartrate at PAINWeek

Next-Generation Tablet Formulation Resists Physical Manipulation and Extraction of Hydrocodone In Vitro Data Supports Further Human Abuse Liability Studies LAS VEGAS, Sept. 9, 2015 (GLOBE...